Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients

被引:151
作者
Sadakata, Tetsushi
Washida, Miwa
Iwayama, Yoshimi
Shoji, Satoshi
Sato, Yumi
Ohkura, Takeshi
Katoh-Semba, Ritsuko
Nakajima, Mizuho
Sekine, Yukiko
Tanaka, Mika
Nakamura, Kazuhiko
Iwata, Yasuhide
Tsuchiya, Kenji J.
Mori, Norio
Detera-Wadleigh, Sevilla D.
Ichikawa, Hironobu
Itohara, Shigeyoshi
Yoshikawa, Takeo
Furuichi, Teiichi [1 ]
机构
[1] RIKEN, Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan
[2] RIKEN, Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan
[3] Tokyo Metropolitan Umegaoka Hosp, Tokyo, Japan
[4] Aichi Human Serv Ctr, Inst Dev Res, Dept Perinatol, Kasugai, Aichi, Japan
[5] RIKEN, Brain Sci Inst, Res Resource Ctr, Wako, Saitama 3510198, Japan
[6] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 43131, Japan
[7] NIMH, Mood & Anxiety Disorders Program, Bethesda, MD 20892 USA
[8] RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan
关键词
D O I
10.1172/JCI29031
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Autism, characterized by profound impairment in social interactions and communicative skills, is the most common neurodevelopmental disorder, and its underlying molecular mechanisms remain unknown. Ca2+-dependent activator protein for secretion 2 (CADPS2; also known as CAPS2) mediates the exocytosis of densecore vesicles, and the human CADPS2 is located within the autism susceptibility locus 1 on chromosome 7q. Here we show that Cadps2-knockout mice not only have impaired brain-derived neurotrophic factor release but also show autistic-like cellular and behavioral phenotypes. Moreover, we found an aberrant alternatively spliced CADPS2 mRNA that lacks exon 3 in some autistic patients. Exon 3 was shown to encode the dynactin 1-binding domain and affect axonal CADPS2 protein distribution. Our results suggest that a disturbance in CADPS2-mediated neurotrophin release contributes to autism susceptibility.
引用
收藏
页码:931 / 943
页数:13
相关论文
共 63 条
[1]   Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders [J].
Aman, MG ;
Langworthy, KS .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2000, 30 (05) :451-459
[2]  
Aman Michael G, 2004, Semin Pediatr Neurol, V11, P225, DOI 10.1016/j.spen.2004.07.006
[3]   Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 [J].
Amir, RE ;
Van den Veyver, IB ;
Wan, M ;
Tran, CQ ;
Francke, U ;
Zoghbi, HY .
NATURE GENETICS, 1999, 23 (02) :185-188
[4]   HISTOANATOMIC OBSERVATIONS OF THE BRAIN IN EARLY INFANTILE-AUTISM [J].
BAUMAN, M ;
KEMPER, TL .
NEUROLOGY, 1985, 35 (06) :866-874
[5]   CAPS (mammalian UNC-31) protein localizes to membranes involved in dense-core vesicle exocytosis [J].
Berwin, B ;
Floor, E ;
Martin, TFJ .
NEURON, 1998, 21 (01) :137-145
[6]   Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system [J].
Bibel, M ;
Barde, YA .
GENES & DEVELOPMENT, 2000, 14 (23) :2919-2937
[7]   Regulation of dense core vesicle release from PC12 cells by interaction between the D2 dopamine receptor and calcium-dependent activator protein for secretion (CAPS) [J].
Binda, AV ;
Kabbani, N ;
Levenson, R .
BIOCHEMICAL PHARMACOLOGY, 2005, 69 (10) :1451-1461
[8]   THE USE OF THE MORRIS WATER MAZE IN THE STUDY OF MEMORY AND LEARNING [J].
BRANDEIS, R ;
BRANDYS, Y ;
YEHUDA, S .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1989, 48 (1-2) :29-69
[9]   SCH-23390 ANTAGONISM OF A D-2 DOPAMINE AGONIST DEPENDS UPON CATECHOLAMINERGIC NEURONS [J].
BREESE, GR ;
MUELLER, RA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 113 (01) :109-114
[10]   The role of selective transport in neuronal protein sorting [J].
Burack, MA ;
Silverman, MA ;
Banker, G .
NEURON, 2000, 26 (02) :465-472